CWWDA · Founding Partner
Twenty Hours, LLC – Chief Executive Officer
Each step in my professional journey has led me to this exciting point. The expertise I’ve honed during the last 25 + years, combined with remarkable advances in science and technology and a powerful network of collaborators and colleagues enables me to begin work to shift the paradigm in healthcare from diagnosing and treating disease to identifying early risk for disease and intercepting disease processes before they progress to illness. These efforts require the integration of many stakeholders, spanning scientific, clinical, regulatory, and commercial – all aligned to a vision, focused on the individual, creating wins for the patient, provider and payer together. When everyone wins, we have a sustainable healthcare system.
I am excited to work with so many visionaries in my role at CWWDA, continuing these efforts. We desire to build on the current set of clinical successes in this space and translate these clinical successes into patient and commercial successes for people and health care systems around the world. And by doing that, attract significant financial and human capital into this field, allowing for the next round of innovations that are necessary… each step getting closer to a world without disease.
I am thankful for my time at United Health group, gaining unique insights into the problems confronting payers as well as how decisions are made in terms of priority and directions. Connecting with a unique set of talent, both inside of United, as well as the many different solution providers UHG interacted with, helped to sharpen my view on what innovation would be needed and potential ways to integrate those solutions for the greatest effect.
My tenure at Johnson & Johnson (J&J) and Janssen was instrumental in planting the seeds of this world without disease vision – to address the root cause(s) of disease, intervene earlier than today’s clinically accepted point of diagnosis and stop, reverse or inhibit the progression to disease. Through a series of disease focused programs, in concert with a team of leading scientists and partners around the world, this experience in accelerating growth opportunities and scouting new and emerging scientific areas to deliver innovative solutions coupled with identifying and piloting new business and funding models has provided the experience to what is needed to bring this to life.
